Starting Time of Presbyopic Eyeglasses Wear and Lifestyle.
accommodation
circadian rhythm
income
lifestyle
near correction
presbyopia
shift work
sleep
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
02
2022
accepted:
17
05
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
7
7
2022
Statut:
epublish
Résumé
Presbyopia is a serious burden in the aged population, however, the factors affecting its progression have not been fully determined. The aim of this study was to explore the association between the time of starting to wear presbyopic eyeglasses and lifestyle, in participants aged from 40 to 59 years. We selected the sample to be representative of sex and age for the age group 40 to 59 We found 529 participants (26.5%) used near correction, with a mean age for first near correction of 47.8±4.8 years. An earlier commencement of near correction correlated with hyperopia ( The current study suggests a healthy sleep habit may delay the need for near correction, in addition to myopia. Shift work and circadian rhythm disruption might exacerbate presbyopia progression.
Identifiants
pubmed: 35784242
doi: 10.3389/fpubh.2022.856999
pmc: PMC9240650
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
856999Informations de copyright
Copyright © 2022 Ayaki, Negishi, Kawashima and Tsubota.
Déclaration de conflit d'intérêts
KT is employed by Tsubota Laboratory, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Exp Optom. 2020 Jan;103(1):21-30
pubmed: 31734940
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2824-30
pubmed: 27227351
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Curr Eye Res. 2020 Jul;45(7):873-878
pubmed: 32045272
Ophthalmology. 2018 Oct;125(10):1492-1499
pubmed: 29753495
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2882-6
pubmed: 12202506
Acta Ophthalmol. 2014 Sep;92(6):497-500
pubmed: 24910300
Pediatr Allergy Immunol. 2020 Apr;31(3):265-272
pubmed: 31829464
Am J Ophthalmol. 2006 Jul;142(1):125-131
pubmed: 16815260
Chronobiol Int. 2019 Sep;36(9):1285-1300
pubmed: 31328571
J Ophthalmol. 2014;2014:943786
pubmed: 25485144
Trans Am Ophthalmol Soc. 1986;84:799-845
pubmed: 3590481
Int Ophthalmol. 2018 Aug;38(4):1809-1816
pubmed: 28688025
Nat Commun. 2021 May 17;12(1):2862
pubmed: 34001884
Adv Exp Med Biol. 2020;1260:193-265
pubmed: 32304036
J Refract Surg. 2008 Sep;24(7):696-701
pubmed: 18811112
Sci Rep. 2020 Feb 13;10(1):2569
pubmed: 32054990
Eur J Cancer. 2012 Jul;48(11):1722-9
pubmed: 21852111
Ophthalmology. 1999 Jun;106(6):1178-81
pubmed: 10366089
Sleep Med Clin. 2017 Mar;12(1):1-22
pubmed: 28159089
Arch Ophthalmol. 2008 Dec;126(12):1731-9
pubmed: 19064856
PLoS One. 2021 Apr 23;16(4):e0250087
pubmed: 33891599
Diabet Med. 2016 Feb;33(2):158-68
pubmed: 26031931
Sci Rep. 2017 Jul 28;7(1):6819
pubmed: 28754903
J Clin Med. 2020 Aug 18;9(8):
pubmed: 32824849
Clin Exp Ophthalmol. 2019 Jan;47(1):106-127
pubmed: 29927057
Ophthalmology. 2008 Aug;115(8):1279-85
pubmed: 18294691
Ageing Res Rev. 2019 Aug;53:100913
pubmed: 31154014
Nat Commun. 2020 Apr 21;11(1):1927
pubmed: 32317636
Free Radic Biol Med. 2018 May 1;119:62-68
pubmed: 29277395
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882